The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Exemestane Actavis 25 mg film-coated tablets



Actavis Group PTC ehfPA1380/083/001

Main Information

Trade NameExemestane Actavis 25 mg film-coated tablets
Active SubstancesExemestane
Dosage FormFilm-coated tablet
Licence HolderActavis Group PTC ehf
Licence NumberPA1380/083/001

Group Information

ATC CodeL02BG Aromatase inhibitors
L02BG06 exemestane

Status

License statusAuthorised
Licence Issued08/10/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back